This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
Kidney Cancer
RadiCal
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
FORT
NRG-GU 0101
Masofaniten (Oral EPI-7386)
RTIRE
SHORTER
SPLASH
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Suprapubic Catheter
Diane K. Newman, DNP FAAN BCB-PMD
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
AMA Interim 2023
SUO 2023
ESMO 2023
IBCN 2023
ASTRO 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
2023 International Bladder Cancer Network
Viewing 1-18 of 18 articles
IBCN 2023: Proteogenomic Characterization of Chemotherapy Response in Muscle Invasive Bladder Cancer
IBCN 2023: Initial Results From The Prospective Randomized UroFollow Trial Comparing Markerguided vs. Cystoscopy-Based Standard Follow-Up In Patients With Low/Intermediate Risk Bladder Cancer
IBCN 2023: Urinary Comprehensive Genomic Profiling Predicts Urothelial Cancer Up To 12 Years Ahead Of Clinical Diagnosis: An Expanded Analysis Of The Golestan Cohort Study
IBCN 2023: A Composite Biomarker Approach to Spare Neoadjuvant Chemotherapy in Select Muscle-Invasive Bladder Cancer Patients
IBCN 2023: Molecular Signatures Predict GEMDOCE Responses for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
IBCN 2023: Simulating The Effects of Molecular Urine Markers In Follow-Up Of Patients With High Risk Non-Muscle Invasive Bladder Cancer
IBCN 2023: Added Value of ctDNA Testing For Identifying FGFR3 Alterations In Metastatic Urothelial Cancer Eligible For Erdafitinib Treatment
IBCN 2023: Gene Expression-Based Classification of Urothelial Carcinoma For Research And Clinical Applications
IBCN 2023: Alignment Of Molecular Subtypes Across Multiple Bladder Cancer Subtyping Classifiers
IBCN 2023: Meta-Analysis of GWAS Data from Diverse Populations for Bladder Cancer (mapBC) Collaboration: Initial Findings
IBCN 2023: Exploring the Impact of Microbiome in the Response of Combined Radiation with Immune Checkpoint Blockade in Muscle Invasive Bladder Cancer
IBCN 2023: Patient-Derived Organoids Identify Tailored Therapeutic Options and Determinants of Plasticity in Sarcomatoid Urothelial Bladder Cancer
IBCN 2023: Field Cancerization Impacts Tumor Development, T-Cell Exhaustion and Clinical Outcomes in Bladder Cancer
IBCN 2023: Evaluation of Molecular Residual Disease by Urinary Comprehensive Genomic Profiling in the SWOG S1605 Phase II Study of Atezolizumab in Patients with BCG Unresponsive NMIBC
IBCN 2023: An Holistic and Intergrated Approach for Investigating the Bacterial Microbiome, Gene Expression Profile and Immune Cell Profile in the Non-Muscle Invasive Bladder Cancer Tumour Microenvironment
IBCN 2023: SURE-01: Interim Results of a Phase 2 Study of Neoadjuvant Sacituzumab Govitecan, Followed by Radical Cystectomy, for Patients with Muscle-Invasive Bladder Cancer
IBCN 2023: Transurethral Resections of Bladder Tumor Quality Criteria and Early Recurrence Rate: Preliminary Data from the International RESECT Study
IBCN 2023: Long Term Recurrence Risk, Metastatic Potential, and Length of Surveillance of Low Grade Non-Muscle Invasive Bladder Cancer
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free